International Pharmaceutical Regulatory Monitor
April 2007
| Vol.
35 No.
4
Integrity and Accountability Warrant New Office Within U.S. FDA
U.S. Food and Drug Administration (FDA) Commissioner Andrew von Eschenbach has announced the creation of a new office that will address cultural issues within the agency.
This article is viewable by subscribers only. To view this article, please select an option below.
|